These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23218689)

  • 1. Treatment of diabetic macular edema with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I/II study.
    Campochiaro PA; Channa R; Berger BB; Heier JS; Brown DM; Fiedler U; Hepp J; Stumpp MT
    Am J Ophthalmol; 2013 Apr; 155(4):697-704, 704.e1-2. PubMed ID: 23218689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of exudative age-related macular degeneration with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I/II study.
    Souied EH; Devin F; Mauget-Faÿsse M; Kolář P; Wolf-Schnurrbusch U; Framme C; Gaucher D; Querques G; Stumpp MT; Wolf S;
    Am J Ophthalmol; 2014 Oct; 158(4):724-732.e2. PubMed ID: 24907435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema.
    Nguyen QD; Tatlipinar S; Shah SM; Haller JA; Quinlan E; Sung J; Zimmer-Galler I; Do DV; Campochiaro PA
    Am J Ophthalmol; 2006 Dec; 142(6):961-9. PubMed ID: 17046701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aqueous humor levels of vascular endothelial growth factor and adiponectin in patients with type 2 diabetes before and after intravitreal bevacizumab injection.
    Costagliola C; Daniele A; dell'Omo R; Romano MR; Aceto F; Agnifili L; Semeraro F; Porcellini A
    Exp Eye Res; 2013 May; 110():50-4. PubMed ID: 23454098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema.
    Do DV; Nguyen QD; Shah SM; Browning DJ; Haller JA; Chu K; Yang K; Cedarbaum JM; Vitti RL; Ingerman A; Campochiaro PA
    Br J Ophthalmol; 2009 Feb; 93(2):144-9. PubMed ID: 19174400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqueous humour levels of vascular endothelial growth factor and erythropoietin in patients with diabetic macular oedema before and after intravitreal erythropoietin injection.
    Lim JW; Han JR
    Clin Exp Ophthalmol; 2011 Aug; 39(6):537-44. PubMed ID: 21819507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.
    Do DV; Schmidt-Erfurth U; Gonzalez VH; Gordon CM; Tolentino M; Berliner AJ; Vitti R; Rückert R; Sandbrink R; Stein D; Yang K; Beckmann K; Heier JS
    Ophthalmology; 2011 Sep; 118(9):1819-26. PubMed ID: 21546089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of diabetic macular edema with an inhibitor of vascular endothelial-protein tyrosine phosphatase that activates Tie2.
    Campochiaro PA; Sophie R; Tolentino M; Miller DM; Browning D; Boyer DS; Heier JS; Gambino L; Withers B; Brigell M; Peters K
    Ophthalmology; 2015 Mar; 122(3):545-54. PubMed ID: 25439435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, dose-escalation study of subconjunctival and intravitreal injections of sirolimus in patients with diabetic macular edema.
    Dugel PU; Blumenkranz MS; Haller JA; Williams GA; Solley WA; Kleinman DM; Naor J
    Ophthalmology; 2012 Jan; 119(1):124-31. PubMed ID: 22115710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab.
    Funk M; Schmidinger G; Maar N; Bolz M; Benesch T; Zlabinger GJ; Schmidt-Erfurth UM
    Retina; 2010 Oct; 30(9):1412-9. PubMed ID: 20711086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema.
    Sohn HJ; Han DH; Kim IT; Oh IK; Kim KH; Lee DY; Nam DH
    Am J Ophthalmol; 2011 Oct; 152(4):686-94. PubMed ID: 21782151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of aqueous cytokines in patients with different patterns of diabetic macular edema based on optical coherence tomography.
    Bandyopadhyay S; Bandyopadhyay SK; Saha M; Sinha A
    Int Ophthalmol; 2018 Feb; 38(1):241-249. PubMed ID: 28160192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
    Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K
    Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of 1.25 MG versus 2.5 MG intravitreal bevacizumab for diabetic macular edema: six-month results of a randomized controlled trial.
    Lam DS; Lai TY; Lee VY; Chan CK; Liu DT; Mohamed S; Li CL
    Retina; 2009 Mar; 29(3):292-9. PubMed ID: 19287286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a pilot study.
    Bonini-Filho M; Costa RA; Calucci D; Jorge R; Melo LA; Scott IU
    Am J Ophthalmol; 2009 Jun; 147(6):1022-30, 1030.e1-5. PubMed ID: 19327746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema.
    Kim M; Lee P; Kim Y; Yu SY; Kwak HW
    Ophthalmologica; 2011; 226(3):138-44. PubMed ID: 21822008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema.
    Ozturk BT; Kerimoglu H; Bozkurt B; Okudan S
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):373-7. PubMed ID: 21631366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the effect of intravitreal bevacizumab injection on diabetic macular edema after cataract surgery.
    Takamura Y; Kubo E; Akagi Y
    Ophthalmology; 2009 Jun; 116(6):1151-7. PubMed ID: 19376589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical mecamylamine for diabetic macular edema.
    Campochiaro PA; Shah SM; Hafiz G; Heier JS; Lit ES; Zimmer-Galler I; Channa R; Nguyen QD; Syed B; Do DV; Lu L; Monk J; Cooke JP; Kengatharan MK; Hsu HH
    Am J Ophthalmol; 2010 May; 149(5):839-51.e1. PubMed ID: 20189159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.